Quarterly report [Sections 13 or 15(d)]

Cover

v3.25.1
Cover - $ / shares
 3 Months Ended
Mar. 31, 2025
May 12, 2025
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2025  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --12-31  
Entity File Number 001-40739  
Entity Registrant Name DERMATA THERAPEUTICS, INC.  
Entity Central Index Key 0001853816  
Entity Tax Identification Number 86-3218736  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 3525 Del Mar Heights Rd.  
Entity Address, Address Line Two #322  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92130  
City Area Code 858  
Local Phone Number 800-2543  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   6,378,118
Entity Listing, Par Value Per Share $ 0.0001  
Common Stock, par value $0.0001 [Member]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol DRMA  
Security Exchange Name NASDAQ  
Warrants Exercisable [Member]    
Title of 12(b) Security Warrants, exercisable for one share of Common Stock  
Trading Symbol DRMAW  
Security Exchange Name NASDAQ